These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9565967)

  • 1. L-DOPA exacerbates amphetamine-induced dopamine depletion.
    Myers CS; Witten M; Yu YL; Wagner GC
    Mol Chem Neuropathol; 1998 Feb; 33(2):81-97. PubMed ID: 9565967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotoxic effects of amphetamine plus L-DOPA.
    Myers CS; Halladay AK; Widmer DA; Wagner GC
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 May; 23(4):731-40. PubMed ID: 10390730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.
    Huang L; Deng M; Zhang S; Fang Y; Li L
    Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):685-90. PubMed ID: 24910244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasally applied L-DOPA alleviates parkinsonian symptoms in rats with unilateral nigro-striatal 6-OHDA lesions.
    Chao OY; Mattern C; Silva AM; Wessler J; Ruocco LA; Nikolaus S; Huston JP; Pum ME
    Brain Res Bull; 2012 Feb; 87(2-3):340-5. PubMed ID: 22108632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotransformation of locally applied L-dopa in the corpus striatum of the hemi-parkinsonian rat studied with microdialysis.
    Sarre S; De Klippel N; Herregodts P; Ebinger G; Michotte Y
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jul; 350(1):15-21. PubMed ID: 7935849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR
    Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BIA 3-202, a novel catechol-O-methyltransferase inhibitor, enhances the availability of L-DOPA to the brain and reduces its O-methylation.
    Parada A; Loureiro AI; Vieira-Coelho MA; Hainzl D; Soares-da-Silva P
    Eur J Pharmacol; 2001 May; 420(1):27-32. PubMed ID: 11412836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microdialysis with radiometric monitoring of L-[β-11C]DOPA to assess dopaminergic metabolism: effect of inhibitors of L-amino acid decarboxylase, monoamine oxidase, and catechol-O-methyltransferase on rat striatal dialysate.
    Okada M; Nakao R; Hosoi R; Zhang MR; Fukumura T; Suzuki K; Inoue O
    J Cereb Blood Flow Metab; 2011 Jan; 31(1):124-31. PubMed ID: 20407462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats.
    Treseder SA; Rose S; Jenner P
    Eur J Neurosci; 2001 Jan; 13(1):162-70. PubMed ID: 11135014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tolcapone, a novel catechol-O-methyltransferase inhibitor, on striatal metabolism of L-dopa and dopamine in rats.
    Napolitano A; Zürcher G; Da Prada M
    Eur J Pharmacol; 1995 Feb; 273(3):215-21. PubMed ID: 7737328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS; Starr MS
    Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-evaluation of the L-dopa loading effect on dopamine metabolism in rat striatum.
    el Gemayel G; Trouvin JH; Prioux-Guyonneau M; Jacquot C; Cohen Y
    J Pharm Pharmacol; 1986 Feb; 38(2):134-6. PubMed ID: 2870159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of benserazide on L-DOPA-derived extracellular dopamine levels and aromatic L-amino acid decarboxylase activity in the striatum of 6-hydroxydopamine-lesioned rats.
    Shen H; Kannari K; Yamato H; Arai A; Matsunaga M
    Tohoku J Exp Med; 2003 Mar; 199(3):149-59. PubMed ID: 12703659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous determination of in vivo hydroxylation of tyrosine and tryptophan in rat striatum by microdialysis-HPLC: relationship between dopamine and serotonin biosynthesis.
    Hashiguti H; Nakahara D; Maruyama W; Naoi M; Ikeda T
    J Neural Transm Gen Sect; 1993; 93(3):213-23. PubMed ID: 7692885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo microdialysis to determine the relative pharmacokinetics of drugs.
    Nakashima M; Zhao MF; Nakashima MN; Sakurai M; Sasaki H; Matsuyama K; Ichikawa M
    Biol Pharm Bull; 1996 Jul; 19(7):988-94. PubMed ID: 8839975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic L-DOPA-pretreatment of rats: an electrophysiological and biochemical study in the basal ganglia.
    Jackson DM; Walters JR; Miller LP
    Brain Res; 1982 Nov; 250(2):271-82. PubMed ID: 6129029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of L-dopa loading on 5-HTP decarboxylation in rat brain areas.
    Trouvin JH; Maubrey MC; Raynal H; Jacquot C
    Fundam Clin Pharmacol; 1991; 5(6):497-502. PubMed ID: 1720112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of benserazide on the peripheral and central distribution and metabolism of levodopa after acute and chronic administration in the rat.
    Kent AP; Stern GM; Webster RA
    Br J Pharmacol; 1990 Aug; 100(4):743-8. PubMed ID: 2119841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity.
    Huang L; Deng M; Zhang S; Lu S; Gui X; Fang Y
    Biomed Pharmacother; 2017 Oct; 94():666-678. PubMed ID: 28787702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interactions of cerebral serotonin and catecholamines].
    Watanabe Y
    Nihon Yakurigaku Zasshi; 1983 May; 81(5):365-83. PubMed ID: 6195056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.